<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="368021">
  <stage>Registered</stage>
  <submitdate>16/04/2015</submitdate>
  <approvaldate>7/05/2015</approvaldate>
  <actrnumber>ACTRN12615000442505</actrnumber>
  <trial_identification>
    <studytitle>What is the frequency of central venous catheter-related venous thrombosis in children?</studytitle>
    <scientifictitle>Frequency of and risk factors for central venous catheter-related venous thrombosis in children.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Venous thrombosis in children</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Blood </conditioncode1>
      <conditioncode2>Clotting disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Observational study.

The primary outcome of the study is the frequency of central venous catheter-related venous thrombosis in children receiving central venous catheters at Astrid Lindgrens Children´s Hospital. 
All children receiving central venous catheters at Astrid Lindgrens Children´s Hospital will be included in the study.

Blood sampling for coagulation tests will be obtained at the insertion and extraction of the central venous catheter (CVC). Patients will be followed for clinical signs of CVC-related venous thrombosis as long as the central venous catheter is in place. Ultrasonography will be used to detect asymptomatic thrombosis at the time of CVC removal.

Patients will be followed until hospital discharge. Patients that develop CVC-related thrombosis will be followed until the end of treatment.

</interventions>
    <comparator>Not applicable</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Frequency of central venous catheter-related venous thrombosis assessed by ultrasonography.</outcome>
      <timepoint>Duration of CVC</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>PICU length of stay, data from medical records.</outcome>
      <timepoint>PICU discharge</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Hospital length of stay, data from medical records.</outcome>
      <timepoint>Hospital discharge</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time on mechanical ventilation, data from medical records.</outcome>
      <timepoint>PICU discharge</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>In-hospital mortality, data from medical records.</outcome>
      <timepoint>Hospital discharge</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Short term (in-hospital) complications of venous thrombosis, data from medical records.</outcome>
      <timepoint>Hospital discharge</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with a central venous catheter</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>18</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>- No informed consent.
- Previous thrombosis in the CVC-vein.
- Death is deemed imminent and inevitable.
- CVC inserted during ECMO-treatment</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>Non-parametric statistics will be used to investigate differences between patients with and without CVC-related venous thrombosis. Multivariate analysis will be used to identify risk factors for venous thrombosis. 
he number of participants was chosen based on the expected number of patients meeting inclusion criteria during 12 months in  Astrid Lindgren´s Children Hospital.</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>True</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>20/04/2015</anticipatedstartdate>
    <actualstartdate>20/04/2015</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>240</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Andreas Andersson</primarysponsorname>
    <primarysponsoraddress>Department of Paediatric Anaesthesia and Intensive Care
Astrid Lindgrens Children´s Hospital
S-17176 Stockholm</primarysponsoraddress>
    <primarysponsorcountry>Sweden</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Astrid Lindgren Children´s Hospital (Karolinska University Hospital)</fundingname>
      <fundingaddress>S-17176 Stockholm</fundingaddress>
      <fundingcountry>Sweden</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study investigates the frequency of central venous catheter-related venous thrombosis in children. Further, we want to describe risk factors for the development of central venous catheter-related venous thrombosis in children and short term complications of thrombosis. </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Central ethical review board</ethicname>
      <ethicaddress>FE 289
S-171 77 STOCKHOLM</ethicaddress>
      <ethicapprovaldate>20/03/2015</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Sweden</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Andreas Andersson</name>
      <address>Department of Paediatric Anaesthesia and Intensive Care
Astrid Lindgrens Children´s Hospital
S-17176 Stockholm</address>
      <phone>+46704997886</phone>
      <fax />
      <email>andreas.andersson@karolinska.se</email>
      <country>Sweden</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Andreas Andersson</name>
      <address>Department of Paediatric Anaesthesia and Intensive Care
Astrid Lindgrens Children´s Hospital
S-17176 Stockholm</address>
      <phone>+46704997886</phone>
      <fax />
      <email>andreas.andersson@karolinska.se</email>
      <country>Sweden</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Andreas Andersson</name>
      <address>Department of Paediatric Anaesthesia and Intensive Care
Astrid Lindgrens Children´s Hospital
S-17176 Stockholm</address>
      <phone>+46704997886</phone>
      <fax />
      <email>andreas.andersson@karolinska.se</email>
      <country>Sweden</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Andreas Andersson</name>
      <address>Department of Paediatric Anaesthesia and Intensive Care
Astrid Lindgrens Children´s Hospital
S-17176 Stockholm</address>
      <phone />
      <fax />
      <email />
      <country>Sweden</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>